HCL's performance drove analyst target price changes from various financial institutions, including UBS, Nomura, and Morgan Stanley, on July 1, 2026.
1 report, 1 independent
Updated Jul 1
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
HCL's performance drove analyst target price changes from various financial institutions, including UBS, Nomura, and Morgan Stanley, on July 1, 2026.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
UBS
Swiss multinational investment bank and financial services company
-
CLSA
Capital markets and investment group
-
Nomura
corporation in Japan
-
Morgan Stanley
U.S. investment bank
Related events
- Analyst action influenced stock price targets for companies including UBS, Alphabet Inc., Cantor Fitzgerald, and JPMorgan Chase.
- Analyst rating changes are affecting the stock price of Hutchmed (China) Limited, involving HSBC and Morgan Stanley, with MarketBeat tracking the information.
- Analyst rating targets are increasing across the market, with data aggregated by various financial firms including FactSet and MarketBeat.